| human | Q5 |
| P496 | ORCID iD | 0000-0003-1771-6067 |
| P3829 | Publons author ID | 2236078 |
| P1053 | ResearcherID | L-1152-2016 |
| P1153 | Scopus author ID | 7003421057 |
| P734 | family name | Montini | Q37485801 |
| Montini | Q37485801 | ||
| Montini | Q37485801 | ||
| P735 | given name | Eugenio | Q18012537 |
| Eugenio | Q18012537 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q24316339 | A novel human serine-threonine phosphatase related to the Drosophila retinal degeneration C (rdgC) gene is selectively expressed in sensory neurons of neural crest origin |
| Q40643545 | AAV serotype 2 vectors preferentially integrate into active genes in mice |
| Q36236157 | Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation |
| Q43192156 | Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy |
| Q42428093 | Chromosomal integration of adenoviral vector DNA in vivo. |
| Q45855528 | Comprehensive genomic access to vector integration in clinical gene therapy |
| Q41721059 | Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cells |
| Q88073046 | De(bar)coding aged hematopoiesis in primates |
| Q50918441 | Exclusion of PPEF as the gene causing X-linked juvenile retinoschisis. |
| Q45877442 | Genotoxicity assay for gene therapy vectors in tumor prone Cdkn2a⁻/⁻ mice. |
| Q46402112 | Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice. |
| Q28242708 | Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration |
| Q24308698 | Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region |
| Q22010050 | Identification of SCML2, a second human gene homologous to the Drosophila sex comb on midleg (Scm): A new gene cluster on Xp22 |
| Q37588329 | Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform |
| Q44260023 | In vivo correction of murine tyrosinemia type I by DNA-mediated transposition. |
| Q39042960 | In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells |
| Q39958215 | Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy. |
| Q39691004 | Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial. |
| Q34356914 | Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy |
| Q34356904 | Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. |
| Q45868390 | Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection |
| Q34757287 | Lentiviral vector integration profiles differ in rodent postmitotic tissues |
| Q36660711 | Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer |
| Q35600324 | Lentiviral vector-based insertional mutagenesis identifies genes involved in the resistance to targeted anticancer therapies |
| Q42157448 | Liver-directed lentiviral gene therapy in a dog model of hemophilia B. |
| Q37221675 | Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria. |
| Q22010244 | MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development |
| Q24539178 | Opitz G/BBB syndrome in Xp22: mutations in the MID1 gene cluster in the carboxy-terminal domain |
| Q37453594 | Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy |
| Q33399943 | Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome |
| Q38840298 | Preclinical testing of the safety and tolerability of LV-mediated above normal alpha-L-iduronidase expression in murine and human hematopoietic cells using toxicology and biodistribution GLP studies |
| Q28588241 | Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6 |
| Q45868739 | Quest for safety at AAValon |
| Q38426578 | Relevance of an academic GMP Pan-European vector infra-structure (PEVI). |
| Q40772336 | Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency |
| Q41242075 | Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting. |
| Q41822307 | Targeted genome editing in human repopulating haematopoietic stem cells |
| Q36502887 | Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development |
| Q41317435 | The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis |
| Q37143395 | The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy |
| Q48038871 | The mouse Mid1 gene: implications for the pathogenesis of Opitz syndrome and the evolution of the mammalian pseudoautosomal region |
| Q33649318 | Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy |
| Q36941057 | Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors. |
| Q28383769 | Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo |
| Q41869702 | VISPA: a computational pipeline for the identification and analysis of genomic vector integration sites |
| Q35913748 | Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations. |
| Q39043191 | Wiskott-Aldrich syndrome protein deficiency in natural killer and dendritic cells affects antitumor immunity |
| Q35655756 | adLIMS: a customized open source software that allows bridging clinical and basic molecular research studies |
| Q45855195 | miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic Leukemia |
Search more.